Newsletter | July 7, 2025

07.07.25 -- Should Your CDMO Run 'Technical' Batches?

The Role Of Developability In Lead Candidate Selection

Webinar | Abzena

Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.

Diffucaps For Enhanced Therapeutic Performance

Video | Adare Pharma Solutions

Learn about a versatile controlled-release technology that enables precise, customizable drug delivery for improved solubility, efficacy, and patient outcomes across a range of oral dosage forms.

Large Molecule Development Capacity Update January 2025

Video | KBI Biopharma

Follow along as Derek Ryan, Sr. Director of Analytical Development, showcases our high-throughput technology and digital tools for process understanding and optimizing decision-making.

Should Your CDMO Run 'Technical' Batches?

Video | Outsourced Pharma

Our panel pitches in on the need for "extra" technical, tox or engineering batches to further ensure manufacturing success, and considering tight budgets at biotechs.

Deliver What's Next With A Cell Therapy Manufacturing Platform

Video | Cytiva

Streamline CAR T cell therapy manufacturing with an end-to-end solution featuring two automated systems that optimize every stage from cell isolation to final therapeutic dose.

A Targeted Molecular Method For Sensitive Viral Detection In Just Days

Video | MilliporeSigma

Explore the motivations, scientific breakthroughs, and collaborative efforts that contributed to the development of this innovative testing solution to help drive safer, animal-free biomanufacturing solutions.